Get started
Author

Yosuke Kito

Observed names: Kito Yosuke, Kito, Yosuke, Y. Kito
ORCID: 0000-0003-3677-9880
Observed ORCID: 0000-0003-3677-9880
OpenAlex ID: A5044702819
Regorafenib Versus Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: A Retrospective Comparison
2016 · Toshiki Masuishi, Hiroya Taniguchi, et al. · Clinical Colorectal Cancer · 74
Risk factors for esophageal fistula in thoracic esophageal squamous cell carcinoma invading adjacent organs treated with definitive chemoradiotherapy: a monocentric case-control study
2018 · Takeshi Kawakami, Takahiro Tsushima, et al. · BMC Cancer · 57
PDF
Neutropenia as a Predictive Factor in Metastatic Colorectal Cancer Treated With TAS-102
2016 · Satoshi Hamauchi, Kentaro Yamazaki, et al. · Clinical Colorectal Cancer · 57
Gastrojejunostomy versus duodenal stent placement for gastric outlet obstruction in patients with unresectable pancreatic cancer
2017 · Yukio Yoshida, Akira Fukutomi, et al. · Pancreatology · 49
Role of hepatectomy in gastric cancer with multiple liver-limited metastases
2017 · Hiromichi Shirasu, Takahiro Tsushima, et al. · Gastric Cancer · 42
PDF
Risk factors for aspiration pneumonia after definitive chemoradiotherapy or bio-radiotherapy for locally advanced head and neck cancer: a monocentric case control study
2017 · Sadayuki Kawai, Tomoya Yokota, et al. · BMC Cancer · 41
PDF
Establishment and validation of prognostic nomograms in first-line metastatic gastric cancer patients
2018 · Yukiya Narita, Shigenori Kadowaki, et al. · Journal of Gastrointestinal Oncology · 36
PDF
Real-world effectiveness of nivolumab in advanced gastric cancer: the DELIVER trial (JACCRO GC-08)
2021 · Yoshikazu Takahashi, Yu Sunakawa, et al. · Gastric Cancer · 35
PDF
Efficacy and safety of irinotecan monotherapy as third-line treatment for advanced gastric cancer
2016 · Takeshi Kawakami, Nozomu Machida, et al. · Cancer Chemotherapy and Pharmacology · 34
Detection of pharyngeal cancer in the overall population undergoing upper GI endoscopy by using narrow-band imaging: a single-center experience, 2009–2012
2013 · Hiroyoshi Nakanishi, Hisashi Doyama, et al. · Gastrointestinal Endoscopy · 30
Genomic pathway of gut microbiome to predict efficacy of nivolumab in advanced gastric cancer: DELIVER trial (JACCRO GC-08).
2021 · Yu Sunakawa, Ryo Matoba, et al. · Journal of Clinical Oncology · 25
Hypomagnesemia Associated with a Proton Pump Inhibitor
2012 · Jun Matsuyama, Kunihiro Tsuji, et al. · Internal Medicine · 24
PDF
Soluble programmed cell death ligand 1 predicts prognosis for gastric cancer patients treated with nivolumab: Blood-based biomarker analysis for the DELIVER trial
2023 · Hisato Kawakami, Yu Sunakawa, et al. · European Journal of Cancer · 22
Prominent PD-L1-positive M2 macrophage infiltration in gastric cancer with hyper-progression after anti-PD-1 therapy
2021 · Kyoko Yamaguchi, Kenji Tsuchihashi, et al. · Medicine · 14
Serum CA19-9 Response Is an Early Predictive Marker of Efficacy of Regorafenib in Refractory Metastatic Colorectal Cancer
2017 · Azusa Komori, Hiroya Taniguchi, et al. · Oncology · 14
Use of transoral endoscopy for pharyngeal examination: C ross‐sectional analysis
2013 · Kunihiro Tsuji, Hisashi Doyama, et al. · Digestive Endoscopy · 13
Phase II study of S-1 plus oxaliplatin 130 mg/m2 in Japanese patients with advanced gastric cancer
2018 · Yosuke Kito, Nozomu Machida, et al. · International Journal of Clinical Oncology · 11
Exploration of time points and cut-off values for early tumour shrinkage to predict survival outcomes of patients with metastatic colorectal cancer treated with first-line chemotherapy using a biexponential model for change in tumour size
2017 · Kentaro Sakamaki, Yosuke Kito, et al. · ESMO Open · 10
PDF
BRAF V600E and Non-V600E Mutations in RAS Wild-Type Metastatic Colorectal Cancer: Prognostic and Therapeutic Insights from a Nationwide, Multicenter, Observational Study (J-BROS)
2025 · Hiroya Taniguchi, Kay Uehara, et al. · Cancers · 9
PDF
First report of the randomized phase III study of bi-weekly trifluridine/tipiracil (FTD/TPI) plus bevacizumab (BEV) vs. FTD/TPI monotherapy for chemorefractory metastatic colorectal cancer (mCRC): JCOG2014 (ROBiTS).
2024 · Hironaga Satake, Kentaro Yamazaki, et al. · Journal of Clinical Oncology · 9
PDF
Does previous biopsy lead to cancer overdiagnosis of superficial non-ampullary duodenal epithelial tumors?
2021 · Shigetsugu Tsuji, Hisashi Doyama, et al. · Endoscopy International Open · 9
PDF
The efficacy and safety of FOLFOX therapy for advanced esophageal squamous cell carcinoma
2025 · Kazuhiro Shiraishi, Mao Okada, et al. · Scientific Reports · 8
Trifluridine/Tipiracil Plus Bevacizumab for Vulnerable Patients With Pretreated Metastatic Colorectal Cancer: A Retrospective Study (WJOG14520G)
2023 · Yosuke Kito, Hisato Kawakami, et al. · The Oncologist · 8
PDF
Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in Japan
2022 · Masahiko Aoki, Shigenori Kadowaki, et al. · Gastric Cancer · 8
PDF
CA125 Kinetics as a Potential Biomarker for Peritoneal Metastasis Progression following Taxane-Plus-Ramucirumab Administration in Patients with Advanced Gastric Cancer
2024 · Akira Ueda, Satoshi Yuki, et al. · Cancers · 7
Works count: 135
Citation count: 751
H-index: 14
I10-index: 18
Year
Topic
Type